Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro (R) (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be ...

Key Takeaways Biosimilar insulin glargine access in Europe correlates with significant price reductions of originator products, enhancing affordability and accessibility. The study observed a 21.6 ...

Adults taking Mounjaro in a clinical trial lost on average 48 lb. at the highest dose1,2 Mounjaro delivered superior A1C reductions versus all comparators in phase 3 SURPASS clinical trials6-12 ...

Hong Kong's Department of Health approved Eli Lilly Asia, Inc.'s Mounjaro® (tirzepatide) in KwikPen® presentation, the first and only obesity and type 2 diabetes treatment of its kind that ...

Hong Kong's Department of Health approved Eli Lilly Asia, Inc.'s Mounjaro® (tirzepatide) in KwikPen® presentation, the first and only obesity and type 2 diabetes treatment of its kind that activates ...

In phase 3 SURPASS program, efficacy was evaluated for Mounjaro 5 mg, 10 mg and 15 mg used alone or in combination with commonly prescribed diabetes medications, including metformin, SGLT2 inhibitors, ...

Eli Lilly has announced promising results from the QWINT-1 and QWINT-3 trials, which evaluated once-weekly insulin efsitora alfa (efsitora) for type 2 diabetes. The trial included patients who were ...

Find patient medical information for Insulin Glargine on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings ...

New York, United States , June 12, 2024 (GLOBE NEWSWIRE) -- The Global Insulin Glargine Market Size is to Grow from USD 1.38 Billion in 2023 to USD 2.50 Billion by 2033, at a Compound Annual ...

The side effects of Basaglar, Lantus, Semglee, and Toujeo are expected to be the same. This is because all four medications contain the same active ingredient: insulin glargine.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved a four-dose version (covering a month’s treatment) of the diabetes and weight management medicine Mounjaro (tirzepatide) ...